Search clinical trials for: EMPAGLIFLOZIN PLACEBO
Total 54073 results
-
Boehringer IngelheimEli Lilly and CompanyCompletedObesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Canada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Italy, Poland, Russian Federation, Spain, Greece, Serbia, Thailand, Brazil, Hungary, Argentina
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Ananda Basu, MDNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaboratorsCompletedType 1 DiabetesUnited States
-
Shahid Beheshti University of Medical SciencesRecruitingKidney Transplant; ComplicationsIran, Islamic Republic of
-
University at BuffaloKaleida HealthCompletedAn Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of DapagliflozinType 2 DiabetesUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of Sao PauloRecruitingDiabetes Mellitus, Type 2 | Coronary Heart Disease | Arrythmia, CardiacBrazil
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Vanderbilt University Medical CenterCompletedObesity | Pre-diabetesUnited States
-
Stanford UniversityCompletedLiver Cirrhosis | Cirrhosis | Ascites | Ascites Hepatic | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Zhijun SunEnrolling by invitationHeart Failure | Heart Failure With Preserved Ejection FractionChina
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
University Hospital TuebingenAstraZeneca; German Federal Ministry of Education and Research; German Center...Not yet recruitingRenal Failure | PreDiabetes | Type2diabetesGermany
-
The George InstituteUniversity Medical Center Groningen; Australian and New Zealand Intensive Care...RecruitingAcute Kidney InjuryAustralia
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, Taiwan, India
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited Kingdom
-
Amsterdam UMC, location VUmcRecruitingIdiopathic Pulmonary Arterial HypertensionNetherlands
-
University of Texas Southwestern Medical CenterBoehringer IngelheimCompletedDiabetes Mellitus | Heart Failure, Diastolic | Heart Failure With Preserved Ejection FractionUnited States
-
Zhijun SunEnrolling by invitationHeart Failure | Heart Failure With Preserved Ejection Fraction | Heart Failure With Mid Range Ejection FractionChina
-
Isfahan University of Medical SciencesCompletedDiabetes MellitusIran, Islamic Republic of
-
Amsterdam UMC, location VUmcCompleted
-
Ain Shams UniversityNot yet recruiting
-
Alexandria UniversityRecruitingHeart Failure With Reduced Ejection FractionEgypt
-
Aristotle University Of ThessalonikiUnknownHypertension | Type II DiabetesGreece
-
State University of New York at BuffaloJuvenile Diabetes Research Foundation; University of GlasgowRecruiting
-
Fundación Pública Andaluza para la Investigación...Unknown
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesAustralia, United States, Canada, Mexico, Puerto Rico, Germany, Hungary, Ireland, Poland, Romania, Denmark, Czech Republic, India, Colombia, Finland, United Kingdom
-
Ain Shams UniversityCompletedPharmacokinetics | PharmacogenomicEgypt
-
National Institute on Aging (NIA)CompletedPhysiological Effects of Drugs | Hypoglycemic Agents | Empaglifozin | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Mario Negri Institute for Pharmacological ResearchBoehringer IngelheimWithdrawnObesity | Non-diabetic Chronic Kidney Disease
-
Yaounde Central HospitalCompleted
-
Boehringer IngelheimCompleted
-
University of LeicesterAstraZeneca; Royal Surrey County Hospital NHS Foundation TrustCompletedThe Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes (SINGLED)Type 2 DiabetesUnited Kingdom
-
University Hospital TuebingenWithdrawn
-
University Health Network, TorontoNot yet recruitingEnd Stage Kidney Disease | Kidney Dysfunction | Peritoneal Dialysis Complication | Sodium-glucose Co-transporter-2 Inhibitors | Residual Kidney FunctionCanada
-
Chinese University of Hong KongRecruitingAcute Heart FailureHong Kong
-
Boehringer IngelheimRecruitingHeart FailureKorea, Republic of
-
Assiut UniversityCompleted
-
Mutah UniversityCompletedPharmacokinetic ParametersJordan
-
Medical University of ViennaCompletedPosttransplant Diabetes MellitusAustria
-
McGill University Health Centre/Research Institute...Diabetes CanadaRecruiting
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2China
-
Boehringer IngelheimEli Lilly and CompanyCompletedMyocardial InfarctionUnited States, Spain, Australia, Denmark, Netherlands, Canada, China, Germany, Korea, Republic of, Israel, Hungary, Japan, Argentina, France, Romania, Russian Federation, Serbia, Ukraine, Poland, India, Brazil, Bulgaria
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, United Kingdom, Canada, Italy, Hungary, Spain, Sweden, Australia, Netherlands, France, Czechia, Finland, Germany, Greece, Ireland, Latvia, Mexico, New Zealand, Norway, Poland, Portugal, Romania, Russian Federation, South...
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Japan